Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
  • Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
  • Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
  • Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
<Previous >Next

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

by Jack Cush, Kathryn H. Dao
     
 

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics… See more details below

Overview

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.

Product Details

ISBN-13:
9781455750597
Publisher:
Elsevier Health Sciences
Publication date:
11/15/2012
Series:
Clinics: Internal Medicine
Sold by:
Barnes & Noble
Format:
NOOK Book
Pages:
240
File size:
4 MB

Related Subjects

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >